Topic

New Jersey

A collection of 411 issues

Renewing Orfadin (nitisinone) Approval with Aetna (CVS Health) in New Jersey: Timeline, Documentation & Appeal Process

Answer Box: Key Steps for Orfadin Renewal Success Orfadin (nitisinone) is excluded from Aetna's 2025 specialty formulary, requiring a formulary exception for any coverage. Start renewal 60-90 days early with updated labs (succinylacetone, tyrosine levels, liver function tests), metabolic specialist notes documenting treatment response, and dietary compliance records.
6 min read

How to Get Hemlibra (Emicizumab) Covered by Blue Cross Blue Shield in New Jersey: Complete PA Guide with Appeals Timeline

Answer Box: Getting Hemlibra Covered in New Jersey Horizon Blue Cross Blue Shield of New Jersey covers Hemlibra (emicizumab) as a specialty medication requiring prior authorization through its Medical Injectables Program. First step: Have your hematologist submit a Medical Necessity and Appropriateness Review (MNAR) including hemophilia A diagnosis, inhibitor status,
6 min read

Work With Your Doctor to Get Synagis (Palivizumab) Approved by UnitedHealthcare in New Jersey: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Synagis Covered in New Jersey UnitedHealthcare requires prior authorization for Synagis (palivizumab) in high-risk pediatric patients under 24 months, with coverage limited to 5 monthly doses per RSV season. Your pediatrician must document specific criteria: prematurity (<29 weeks if under 12 months), chronic lung disease requiring
7 min read

How to Get Keppra (Levetiracetam) Covered by Blue Cross Blue Shield in New Jersey: Prior Authorization Guide and Appeal Strategies

Answer Box: Quick Path to Coverage To get Keppra (levetiracetam) covered by Blue Cross Blue Shield in New Jersey: Most plans prefer generic levetiracetam (usually Tier 1-2, no PA required). For brand Keppra, expect prior authorization requiring documented failure/intolerance to generic plus clinical justification. Submit PA via provider portal
6 min read